OX2 Therapeutics is Biotechnology in United States that focus on Checkpoint peptide inhibitor business. Founded in 2016. They cover business area such as operator, primary brain tumor, healthcare institute, receptor, blood vessel wall, cancer activity.
2016
( 8 years old in 2024 )
Checkpoint Peptide Inhibitor
-
1621 East Hennepin Avenue
Suite 290
Minneapolis, MN 55414
United States
Private
operatorprimary brain tumorhealthcare institutereceptorblood vessel wallcancer activity
* We use standard office opening hours in near OX2 Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OX2 Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), OX2 Therapeutics business is focusing on Checkpoint Peptide Inhibitor.
OX2 Therapeutics headquarter office and corporate office address is located in 1621 East Hennepin Avenue Suite 290 Minneapolis, MN 55414 United States.
OX2 Therapeutics was founded in United States.
In 2024, OX2 Therapeutics is currently focus on Checkpoint peptide inhibitor sector.
Above is snippet of Google Trends for "Checkpoint peptide inhibitor" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OX2 Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
